| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T687 |
0-45 |
Sentence |
denotes |
Liu, 202053All Jiangsu ProvinceJiangsuDates: |
| T688 |
46-80 |
Sentence |
denotes |
1/10/2020-2/18/2020Last follow-up: |
| T689 |
81-107 |
Sentence |
denotes |
2/18/2020 n = 620Survival: |
| T690 |
108-181 |
Sentence |
denotes |
0 died, 3.2% in ICU, 56.1% still hospitalized, 40.6% dischargedInclusion: |
| T691 |
182-222 |
Sentence |
denotes |
Inpatient with COVID-10 based on RT-PCR. |
| T692 |
223-281 |
Sentence |
denotes |
Patients without records excluded.Age: m 44.5 ± 17.2 ySex: |
| T693 |
282-338 |
Sentence |
denotes |
47.4% femalesGI/liver comorbidities: NRDisease severity: |
| T694 |
339-410 |
Sentence |
denotes |
15.6% asymptomatic/mild, 75.8% moderate, 8.5% severe/critical Diarrhea: |
| T695 |
411-901 |
Sentence |
denotes |
8.5% (53)Present on admission4/97 asymptomatic/mild, 43/469 moderate, 6/53 severe/critically illNausea, vomiting, and abdominal pain: NR AST (387) m 23.3 ± 18.5m 27.3 ± 14.9 in mild/asymptomatic, 32.3 ± 17.5 in moderate, 42.9 ± 28.6 in severe/critically illALT (420) m 31.0 ± 22.4m 26.8 ± 21.6 in asymptomatic/mild, m 31.2 ± 21.1 in moderate, m 39.3 ± 32.5 in severe/critically illBilirubin (460) m 0.6 ± 0.4m 0.7 ± 0.5 mild/asymptomatic, m 0.6 ± 0.4 moderate, m 0.7 ± 0.4 severe/critically |
